We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MassachusettsDepartment of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
Dian L. Baker
Affiliation:
School of Nursing, California State University, Sacramento, California
*
Author for correspondence: Michael Klompas, E-mail: [email protected]
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
Magill, SS, O’Leary, E, Janelle, SJ, et al.Changes in prevalence of healthcare-associated Infections in US hospitals. N Engl J Med2018;379:1732–1744.Google Scholar
2
Magill, SS, O’Leary, E, Ray, SM, et al. Antimicrobial use in US hospitals: comparison of results from emerging infections program prevalence surveys, 2015 and 2011. Clin Infect Dis2021;72:1784–1792.Google Scholar
3
Corrado, RE, Lee, D, Lucero, DE, Varma, JK, Vora, NM.Burden of adult community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia: New York City, 2010 to 2014. Chest2017;152:930–942.Google ScholarPubMed
4
Klompas, M.Does this patient have ventilator-associated pneumonia?JAMA2007;297:1583–1593.Google ScholarPubMed
5
Fernando, SM, Tran, A, Cheng, W, et al.Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive Care Med2020;46:1170–1179.Google ScholarPubMed
6
Kuti, EL, Patel, AA, Coleman, CI.Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care2008;23:91–100.Google ScholarPubMed
7
Tejerina, E, Esteban, A, Fernandez-Segoviano, P, et al.Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings. J Crit Care2010;25:62–68.Google ScholarPubMed
8
Weiner-Lastinger, LM, Abner, S, Edwards, JR, et al.Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol2020;41:1–18.Google Scholar
9
Bergin, SP, Coles, A, Calvert, SBet al.PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU. Chest2020; 158: 2370-2380Google ScholarPubMed
10
Zilberberg, MD, Nathanson, BH, Puzniak, LA, Shorr, A.Microbiology, empiric therapy and its impact on the outcomes of non-ventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014–2019.Infect Control Hosp Epidemiol2021.Google Scholar
11
Micek, ST, Chew, B, Hampton, N, Kollef, MH.A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest2016;150:1008–1014.Google ScholarPubMed
12
Hong, HL, Hong, SB, Ko, GB, et al.Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One2014;9:e95865.Google ScholarPubMed
13
Chow, EJ, Mermel, LA.Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients. Open Forum Infect Dis2017;4:ofx006.Google ScholarPubMed
14
Rhee, C, Kadri, SS, Dekker, JP, et al.Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open2020;3:e202899.Google ScholarPubMed
15
Jones, BE, Ying, J, Stevens, V, et al.Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern Med2020;180:552–560.Google ScholarPubMed
16
Klompas, M, Calandra, T, Singer, M.Antibiotics for sepsis-finding the equilibrium. JAMA2018;320:1433–1434.Google ScholarPubMed
17
Prescott, HC, Iwashyna, TJ.Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc2019;16:426–429.Google ScholarPubMed
18
Fagon, JY, Chastre, J, Wolff, M, et al.Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med2000;132:621–630.Google ScholarPubMed
19
Hranjec, T, Rosenberger, LH, Swenson, B, et al.Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis2012;12:774–780.Google ScholarPubMed
20
Ramsamy, Y, Muckart, DJ, Bruce, JL, Hardcastle, TC, Han, KS, Mlisana, KP.Empirical antimicrobial therapy for probable v. directed therapy for possible ventilator-associated pneumonia in critically injured patients. S Afr Med J2016;106:196–200.Google ScholarPubMed
21
Evans, L, Rhodes, A, Alhazzani, W, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med2021;49:e1063–e1143.Google ScholarPubMed
22
Zilberberg, MD, Nathanson, BH, Puzniak, LA, Shorr, AF.Descriptive epidemiology and outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012–2019. Crit Care Med2021. doi: 10.1097/CCM.0000000000005298.Google Scholar
23
Munro, SC, Baker, D, Giuliano, KK, et al.Nonventilator hospital-acquired pneumonia: a call to action. Infect Control Hosp Epidemiol2021;42:991–996.Google ScholarPubMed
24
Lacerna, CC, Patey, D, Block, L, et al.A successful program preventing nonventilator hospital-acquired pneumonia in a large hospital system. Infect Control Hosp Epidemiol2020;41:547–552.Google Scholar